Additionally, analysis of cancer cell lines indicated elevated PLEK2 expression in specific cancer types, such as malignant neoplasms of the digestive system, bladder, head and neck, cervix, thyroid, lung, pleural mesothelioma, and breast cancer (Fig. 1e). This evidence concerns the gene PLEK2 and breast carcinoma.